June 11, 2018
Takeda Pharmaceutical’s inflammatory bowel disease medicine Entyvio (vedolizumab) has cleared a key health ministry panel for the treatment of ulcerative colitis (UC), putting it in line for an official stamp of approval as early as this month if all goes...read more